RIGL stock


Rigel Pharmaceuticals [RIGL] fell -13.10% so far this year. What now?

Rigel Pharmaceuticals [NASDAQ: RIGL] price plunged by -2.33 percent to reach at -$0.03. The company report on April 4, 2024 at 8:05 AM that Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphoma. Olutasidenib induced